Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Dec 19;13(12):e0007787.
doi: 10.1371/journal.pntd.0007787. eCollection 2019 Dec.

The Joint Mobile Emerging Disease Clinical Capability (JMEDICC) laboratory approach: Capabilities for high-consequence pathogen clinical research

Prossy Naluyima  1 , Willy Kayondo  1 , Chi Ritchie  2 , Joseph Wandege  1 , Sharon Kagabane  1 , Lydia Tumubeere  1 , Brenda Kusiima  3 , Daniel Kibombo  3 , Sharon Atukunda  1 , Christine Nanteza  1 , Harriet Nabirye  1 , Francis Bunjo Mugabi  1 , Sarah Namuyanja  3 , Christopher Hatcher  2 , Hypaitia Rauch  2 , Moses Mukembo  4 , Patrick Musinguzi  4 ; JMEDICC Consortium; Nathan Sanders  5 , Elizabeth Turesson  6 , Christian Cando  7 , Richard Walwema  3 , Derrick Mimbe  1 , Janice Hepburn  8 , Danielle Clark  8 , Mohammed Lamorde  3 , Hannah Kibuuka  1 , Saima Zaman  7 , Anthony P Cardile  2 , Karen A Martins  2
Affiliations
Review

The Joint Mobile Emerging Disease Clinical Capability (JMEDICC) laboratory approach: Capabilities for high-consequence pathogen clinical research

Prossy Naluyima et al. PLoS Negl Trop Dis. .

Abstract

Following the 2013-2016 Ebola virus outbreak in West Africa, numerous groups advocated for the importance of executing clinical trials in outbreak settings. The difficulties associated with obtaining reliable data to support regulatory approval of investigational vaccines and therapeutics during that outbreak were a disappointment on a research and product development level, as well as on a humanitarian level. In response to lessons learned from the outbreak, the United States Department of Defense established a multi-institute project called the Joint Mobile Emerging Disease Intervention Clinical Capability (JMEDICC). JMEDICC's primary objective is to establish the technical capability in western Uganda to execute clinical trials during outbreaks of high-consequence pathogens such as the Ebola virus. A critical component of clinical trial execution is the establishment of laboratory operations. Technical, logistical, and political challenges complicate laboratory operations, and these challenges have been mitigated by JMEDICC to enable readiness for laboratory outbreak response operations.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Map of Uganda and the bordering area of the DRC.
Fort Portal, the JMEDICC hub site in Uganda, is located in the western part of Uganda near the border with the DRC and is circled in red; Beni and Butembo in DRC, sites of the 2018–present DRC Ebola virus outbreak, also shown and circled in red. Map taken from the CIA website the Uganda Physiography map https://www.cia.gov/library/publications/resources/cia-maps-publications/Uganda.html. CIA, Central Intelligence Agency; DRC, Democratic Republic of Congo; JMEDICC, Joint Mobile Emerging Disease Intervention Clinical Capability.
Fig 2
Fig 2
JMEDICC execution schematic highlighting (A) JMEDICC approach of increasing complexity as competency is established and (B) the multifaceted nature of the project preparedness and response. JMEDICC, Joint Mobile Emerging Disease Clinical Capability.
See this image and copyright information in PMC

References

    1. CDC. 2014–2016 Ebola Outbreak in West Africa. https://wwwcdcgov/vhf/ebola/history/2014-2016-outbreak/indexhtml. - PMC - PubMed
    1. Olu OO, Lamunu M, Chimbaru A, Adegboyega A, Conteh I, Nsenga N, et al. Incident Management Systems Are Essential for Effective Coordination of Large Disease Outbreaks: Perspectives from the Coordination of the Ebola Outbreak Response in Sierra Leone. Front Public Health. 2016;4:254 10.3389/fpubh.2016.00254 - DOI - PMC - PubMed
    1. Gostin LO, Friedman EA. Ebola: a crisis in global health leadership. Lancet. 2014;384(9951):1323–5. 10.1016/S0140-6736(14)61791-8 . - DOI - PubMed
    1. Gates B. The next epidemic—lessons from Ebola. N Engl J Med. 2015;372(15):1381–4. 10.1056/NEJMp1502918 . - DOI - PubMed
    1. Castillo-Chavez C, Curtiss R, Daszak P, Levin SA, Patterson-Lomba O, Perrings C, et al. Beyond Ebola: lessons to mitigate future pandemics. Lancet Glob Health. 2015;3(7):e354–5. 10.1016/S2214-109X(15)00068-6 . - DOI - PMC - PubMed

Publication types

MeSH terms